Saeki, I., Yamasaki, T., Maeda, M., Kawano, R., Hisanaga, T., Iwamoto, T., . . . Sakaida, I. (2018). No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma. Liver Cancer.
Styl ChicagoSaeki, Issei, et al. "No Muscle Depletion With High Visceral Fat As a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma." Liver Cancer 2018.
Citace podle MLASaeki, Issei, et al. "No Muscle Depletion With High Visceral Fat As a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma." Liver Cancer 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..